Imagion Biosystems Limited
IBXXF
$0.015
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.20K | 8.10K | 335.60K | 345.10K | 538.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.20K | 8.10K | 335.60K | 345.10K | 538.70K |
| Cost of Revenue | 195.90K | 191.80K | 22.20K | 22.80K | 109.70K |
| Gross Profit | -187.70K | -183.80K | 313.40K | 322.30K | 429.10K |
| SG&A Expenses | 179.80K | 176.10K | 253.80K | 261.00K | 606.40K |
| Depreciation & Amortization | 1.40K | 1.40K | 2.50K | 2.60K | 126.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 377.10K | 369.30K | 278.60K | 286.50K | 842.70K |
| Operating Income | -368.90K | -361.20K | 57.00K | 58.60K | -304.00K |
| Income Before Tax | -532.20K | -521.10K | -176.00K | -181.00K | -503.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -532.20K | -521.10K | -176.00K | -181.00K | -503.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -532.20K | -521.10K | -176.00K | -181.00K | -503.10K |
| EBIT | -368.90K | -361.20K | 57.00K | 58.60K | -304.00K |
| EBITDA | -367.40K | -359.80K | 64.80K | 106.90K | -177.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 201.34M | 201.34M | 57.27M | 57.27M | 32.65M |
| Average Diluted Shares Outstanding | 201.34M | 201.34M | 57.27M | 57.27M | 32.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |